Litcius/Paper detail

Association Between Sublingual Buprenorphine-Naloxone Exposure and Dental Disease

Mahyar Etminan, Ramin Rezaeianzadeh, Abbas Kezouh, Kevin Aminzadeh

2022JAMA24 citationsDOI

Abstract

This study examines the association of sublingual buprenorphine/naloxone and dental adverse events using the IQVIA health claims database.

Topics & Concepts

MedicineBuprenorphine(+)-NaloxoneAdverse effectSublingual administrationAnesthesiaOpioidPharmacologyInternal medicineReceptorOpioid Use Disorder TreatmentSubstance Abuse Treatment and OutcomesHIV, Drug Use, Sexual Risk